Zemcelpro® distribution agreement announced for Argentina, Hong Kong and Singapore

Contributed by: PR Newswire

Images

PR Newswire associated0
PR Newswire associated1

Tags

ExCellThera-agreement

More Like This

Zemcelpro® (UM171 Cell Therapy) licensing and supply agreements announced for Canada

PR Newswire associated0

Zemcelpro® (UM171 Cell Therapy) receives EC authorization as the first and only cell therapy for blood cancer patients without access to suitable donor cells

PR Newswire associated0

Zemcelpro® (dorocubicel) receives NUB Status 1 in Germany

PR Newswire associated0

Zemcelpro® (UM171 Cell Therapy) receives positive CHMP opinion for treatment of blood cancer patients without access to suitable donor cells

PR Newswire associated0

Zemcelpro® (dorocubicel) Positive Results in High- and Very High-Risk Blood Cancers to be Reported at the EBMT 2026 Annual Meeting

Miltenyi Biomedicine presents primary analysis of the pivotal DALY 2-EU trial for second-line relapsed/refractory large B-cell lymphoma at the 67th American Society of Hematology (ASH) Annual Meeting

Porton Advanced's UC-MSCs Cell Bank for Exosome Manufacturing Receives U.S. FDA Drug Master File (DMF) Acceptance

Business Wire logo

Celltrion Expands Biosimilar Portfolio in the European Union Following European Commission Approval of Two Biosimilars